(rec)hCG

BIOLOGICAL2 trials

Sponsors

Organon and Co

Conditions

In Vitro FertilizationNeonatesPregnancy

Phase 3

Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)

CompletedNCT00696878

Organon and CoIn Vitro Fertilization

Start: 2006-09-26End: 2009-05-15Updated: 2024-06-18

Unknown Phase

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)

CompletedNCT00702234

Organon and CoNeonates, Pregnancy

Start: 2007-02-15End: 2010-01-15Updated: 2024-09-05

Related Papers

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol

PLoS ONE2016-03-0792 citations

Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol.

2015-07-1522 citations

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.

2011-05-2725 citations